DID YOU KNOW? DTIC has over 3.5 million final reports on DoD funded research, development, test, and evaluation activities available to our registered users. Click HERE
to register or log in.
Women's Ischemia Trial to Reduce Events in Non-Obstructive CAD (WARRIOR)
[Technical Report, Annual Report]
FLORIDA UNIV GAINESVILLE
Pagination or Media Count:
The WARRIOR trial is a multicenter, prospective, randomized, blinded outcome evaluation PROBE design evaluatingintensive medical therapy vs usual care in 4,422 symptomatic women with ischemia but no obstructive CAD. The studyaims to determine whether an intensive medication treatment strategy to modify risk factors in women with chest painandor abnormal stress tests, but non-obstructed coronary arteries will reduce their likelihood of dying, having a heartattack, stroke or being hospitalized. This project will activate 50-125 recruitment sites from across the US to enroll andfollow these women for up to three years to assess adverse outcomes.
[A, Approved For Public Release]